Pulmonary hypertension as a risk factor for death in patients with sickle cell disease

被引:926
作者
Gladwin, MT
Sachdev, V
Jison, ML
Shizukuda, Y
Plehn, JF
Minter, K
Brown, B
Coles, WA
Nichols, JS
Ernst, I
Hunter, LA
Blackwelder, WC
Schechter, AN
Rodgers, GP
Castro, O
Ognibene, FP
机构
[1] NHLBI, Dept Crit Care Med, Ctr Clin, NIH, Bethesda, MD 20892 USA
[2] NHLBI, Cardiovasc Branch, NIH, Bethesda, MD 20892 USA
[3] NIDDKD, Lab Chem Biol, NIH, Bethesda, MD 20892 USA
[4] NIDDKD, Mol & Clin Hematol Branch, NIH, Bethesda, MD 20892 USA
[5] Howard Univ, Coll Med, Dept Med, Div Cardiol, Washington, DC USA
[6] Howard Univ, Coll Med, Ctr Sickle Cell Dis, Washington, DC USA
关键词
D O I
10.1056/NEJMoa035477
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The prevalence of pulmonary hypertension in adults with sickle cell disease, the mechanism of its development, and its prospective prognostic significance are unknown. METHODS: We performed Doppler echocardiographic assessments of pulmonary-artery systolic pressure in 195 consecutive patients (82 men and 113 women; mean [+/-SD] age, 36+/-12 years). Pulmonary hypertension was prospectively defined as a tricuspid regurgitant jet velocity of at least 2.5 m per second. Patients were followed for a mean of 18 months, and data were censored at the time of death or loss to follow-up. RESULTS: Doppler-defined pulmonary hypertension occurred in 32 percent of patients. Multiple logistic-regression analysis, with the use of the dichotomous variable of a tricuspid regurgitant jet velocity of less than 2.5 m per second or 2.5 m per second or more, identified a self-reported history of cardiovascular or renal complications, increased systolic blood pressure, high lactate dehydrogenase levels (a marker of hemolysis), high levels of alkaline phosphatase, and low transferrin levels as significant independent correlates of pulmonary hypertension. The fetal hemoglobin level, white-cell count, and platelet count and the use of hydroxyurea therapy were unrelated to pulmonary hypertension. A tricuspid regurgitant jet velocity of at least 2.5 m per second, as compared with a velocity of less than 2.5 m per second, was strongly associated with an increased risk of death (rate ratio, 10.1; 95 percent confidence interval, 2.2 to 47.0; P<0.001) and remained so after adjustment for other possible risk factors in a proportional-hazards regression model. CONCLUSIONS: Pulmonary hypertension, diagnosed by Doppler echocardiography, is common in adults with sickle cell disease. It appears to be a complication of chronic hemolysis, is resistant to hydroxyurea therapy, and confers a high risk of death. Therapeutic trials targeting this population of patients are indicated.
引用
收藏
页码:886 / 895
页数:10
相关论文
共 44 条
[11]   PULMONARY-HYPERTENSION AND COR-PULMONALE IN THE SICKLE HEMOGLOBINOPATHIES [J].
COLLINS, FS ;
ORRINGER, EP .
AMERICAN JOURNAL OF MEDICINE, 1982, 73 (06) :814-821
[12]   NITRIC-OXIDE DECREASES CYTOKINE-INDUCED ENDOTHELIAL ACTIVATION - NITRIC-OXIDE SELECTIVELY REDUCES ENDOTHELIAL EXPRESSION OF ADHESION MOLECULES AND PROINFLAMMATORY CYTOKINES [J].
DECATERINA, R ;
LIBBY, P ;
PENG, HB ;
THANNICKAL, VJ ;
RAJAVASHISTH, TB ;
GIMBRONE, MA ;
SHIN, WS ;
LIAO, JK .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) :60-68
[13]   Pulmonary hypertension in patients with thalassemia major [J].
Derchi, G ;
Fonti, A ;
Forni, GL ;
Cappellini, MD ;
Turati, F .
AMERICAN HEART JOURNAL, 1999, 138 (02) :384-384
[14]   Pulmonary hypertension in patients with thalassemia major [J].
Du, ZD ;
Roguin, N ;
Milgram, E ;
Saab, K ;
Koren, A .
AMERICAN HEART JOURNAL, 1997, 134 (03) :532-537
[15]   Causes of sudden natural death in Jamaica: a medicolegal (coroner's) autopsy study from the University Hospital of the West Indies [J].
Escoffery, CT ;
Shirley, SE .
FORENSIC SCIENCE INTERNATIONAL, 2002, 129 (02) :116-121
[16]   Divergent nitric oxide bioavailability in men and women with sickle cell disease [J].
Gladwin, MT ;
Schechter, AN ;
Ognibene, FP ;
Coles, WA ;
Reiter, CD ;
Schenke, WH ;
Csako, G ;
Waclawiw, MA ;
Panza, JA ;
Cannon, RO .
CIRCULATION, 2003, 107 (02) :271-278
[17]   CARDIOPULMONARY ASSESSMENT IN BETA-THALASSEMIA MAJOR [J].
GRISARU, D ;
RACHMILEWITZ, EA ;
MOSSERI, M ;
GOTSMAN, M ;
LAFAIR, JS ;
OKON, E ;
GOLDFARB, A ;
HASIN, Y .
CHEST, 1990, 98 (05) :1138-1142
[18]   Right ventricular cardiomyopathy in β-thalassaemia major [J].
Hahalis, G ;
Manolis, AS ;
Apostolopoulos, D ;
Alexopoulos, D ;
Vagenakis, AG ;
Zoumbos, NC .
EUROPEAN HEART JOURNAL, 2002, 23 (02) :147-156
[19]   Endothelin-1 production during the acute chest syndrome in sickle cell disease [J].
Hammerman, SI ;
Kourembanas, S ;
Conca, TJ ;
Tucci, M ;
Brauer, M ;
Farber, HW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (01) :280-285
[20]   Pulmonary hypertension in sickle cell hemoglobinopathy: A clinicopathologic study of 20 cases [J].
Haque, AK ;
Gokhale, S ;
Rampy, BA ;
Adegboyega, P ;
Duarte, A ;
Saldana, MJ .
HUMAN PATHOLOGY, 2002, 33 (10) :1037-1043